Digital Therapeutics enter Japanese Market In an ambitious move that marks a significant milestone in the field of digital therapeutics, Akili Interactive has announced its plans to introduce its groundbreaking ADHD treatment, EndeavorRx, to the Japanese market. This initiative comes on the heels of the digital therapeutic’s landmark approval by the U.S. FDA in 2020,…